Targeted disruption of mitochondria potently reverses multidrug resistance in cancer therapy-Reference-Cited by-同舟云学术

Targeted disruption of mitochondria potently reverses multidrug resistance in cancer therapy

Published:2022-02-15 Issue:13 Volume:179 Page:3346-3362
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Liu Dingkang¹^ORCID,Rong Haibo²,Chen Ye¹,Wang Qun¹,Qian Sijia¹,Ji Yue¹,Yao Wenbing¹,Yin Jun¹^ORCID,Gao Xiangdong¹^ORCID

Affiliation:

1. Jiangsu Key Laboratory of Druggability of Biopharmaceuticals and State Key Laboratory of Natural Medicines, School of Life Science and Technology China Pharmaceutical University Nanjing China

2. Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research The Affiliated Cancer Hospital of Nanjing Medical University Nanjing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15801

Reference49 articles.

1. Molecular engineering solutions for therapeutic peptide delivery

2. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes

3. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Transporters

4. Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology

5. Regulation of Cholesterol Homeostasis by Hedgehog Signaling in Osteoarthritic Cartilage

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial Artificial K⁺ Channel Construction Using MPTPP@5F8 Nanoparticles for Overcoming Cancer Drug Resistance via Disrupting Cellular Ion Homeostasis;Advanced Healthcare Materials;2023-10-05

2. Intrinsic adaptations in OXPHOS power output and reduced tumorigenicity characterize doxorubicin resistant ovarian cancer cells;Biochimica et Biophysica Acta (BBA) - Bioenergetics;2022-11

3. Modulating p-AMPK/mTOR Pathway of Mitochondrial Dysfunction Caused by MTERF1 Abnormal Expression in Colorectal Cancer Cells;International Journal of Molecular Sciences;2022-10-15

4. Therapeutic implication of carbon monoxide in drug resistant cancers;Biochemical Pharmacology;2022-07

5. Tailored protein-conjugated DNA nanoplatform for synergistic cancer therapy;Journal of Controlled Release;2022-06